Abstract: Idiopathic thrombocytopenic purpura (ITP) is the most common cause of acquired thrombocytopenia in children. In 20% of cases, this condition is classified as chronic when the thrombocytopenia is persistent 6 months after diagnosis. The aim of the present study is to identify the potential factors correlating with a favorable outcome in patients with chronic ITP. Some 71 patients affected by ITP were retrospectively analyzed. Results show a higher rate of spontaneous recovery that is statistically significant for patients with platelet count at diagnosis <20,000/μL. These observations suggest the possibility to delay or avoid aggressive surgical treatment for these patients.
Introduction
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low platelet (PLT) count and mucosal bruising that can be either spontaneous or caused by trauma or cutaneous wounds. ITP represents the most common cause of severe acquired thrombocytopenia. The clinical presentation of this disease is characterized by the presence of isolated thrombocytopenia (PLT <150,000/μl); a diagnosis of ITP can be suspected in the absence of other diseases or underlying clinical conditions that could cause a PLT count reduction.
The clinical history of the ITP is usually acute in pediatric patients, where remission of symptoms and platelet count occurs within 6 months from the diagnosis in 80% of cases. In the remaining 20% of cases, thrombocytopenia is still present 6 months after the diagnosis; thus, the disease is classified as chronic [1] [2] [3] [4] [5] . A higher risk of developing a chronic ITP appears to be associated with female gender, age at diagnosis older than 10 years, and PLT count at diagnosis above 20.000/μl [6, 7] .
From a clinical point of view, children affected by chronic ITP may display a cyclical course, pharmacological control of the disease, or a refractory pathway. In some cases, it is possible to observe a spontaneous remission of the disease years after the diagnosis was established. However, it is important to emphasize that patients affected by chronic ITP present with relevant bleeding less frequently than those with acute ITP. The most serious event that chronic ITP with PLT count <20,000 lasting for 12 months can precipitate is an intracranial hemorrhage [8] [9] [10] .
In our study, we analyzed the characteristics and clinical course in a group of children affected by chronic ITP; we report spontaneous remissions and evaluate the parameters correlating with a favorable outcome.
Materials and methods
Patients affected by ITP attending the Division of Paediatric Oncology, Catholic University, Rome were retrospectively evaluated. ITP has been diagnosed as an isolated thrombocytopenia (PLT<150,000) in absence of any underlying causes of thrombocytopenia. On first presentation, all patients were examined physically and tested for full blood count, peripheral blood smear, hemotropic virus serology (Epstein-Barr virus, Cytomegalovirus, Parvovirus B19), autoimmune antibodies (AntiNuclear antibody, anti-DNA antibody). All patients with atypical presentation (hypoplasia/aplasia of multiple cell lines) or candidates for steroid therapy underwent bone marrow aspiration.
The retrospective analysis included patients with chronic disease, i.e., a PLT count lower than 150,000/ μl lasting for more than 6 months after diagnosis. Complete remission was defined as absence of abnormal bruising together with a recovery of the PLT count of at least 100,000/μl for more than 3 months without treatment. Spontaneous remission was defined as remission without splenectomy.
The clinical history of 71 patents affected by ITP was evaluated. Thirty patients (43%) were female, 41 (57%) were male. The mean age at diagnosis was 5 yrs and 4 months (median, 5 yrs). The mean PLT count at the onset of ITP was 15,200/μl with a median of 13,500/μl. Sixty-one out of 71 children in the current analysis had been included in a previous report [11] . In the present study, a larger series of patients was evaluated to further investigate potential factors contributing to spontaneous complete remission. Patients with thrombocytopenia secondary to medications or systemic disease and children with discontinuous follow-up were excluded.
The data on age at presentation (>6months to <10 years, and >0 years), sex (female versus male), PLT count at diagnosis (<20,000/μl versus ≥20,000/μl), bleeding manifestation (graded according to BoltonMaggs Criteria), and treatment were analyzed. The probability of remission after 4 and 8 years for all children included in the study was evaluated using KaplanMeier survival analysis (confidence interval/CI 95%).
Results
Among 71 patients affected by ITP, 31 children (44%) had a past history of upper tract respiratory infection before the onset of thrombocytopenia. Thirty-nine children (55%) underwent bone marrow aspiration that showed an increased number and size of megakaryocytes in the absence of atypical cells. Table 1 .
male (mean age 7 yrs and 2 months; median 7 yrs) and 4 were female (mean age 9 yrs, median 8 yrs 6 months).
In the group of patients with chronic ITP, mean PLT count at diagnosis was 23,500/μl (ranging from 3,000/ μl to 53,000/μl), with a median value of 17,000/μl. At 6 months from diagnosis, the mean PLT count in patients with chronic ITP was 34,000/μl (ranging from 2,000/μl to 94,000/μl) and median 29,000/μl. The median follow-up period after ITP diagnosis was 92 months (ranging from 11 to 168 months) ( Table 1) . At their first presentation, 11 children (78%) were treated with a steroid (prednisone 2 mg/kg/day for 2-3 weeks), 8 children (57%) were treated with immunoglobulins i.v. (0.8-1 mg/kg/day for 1-2 days or 400 mg/ kg/day for 5 days); only in the one case with refractory disease, Ig anti-D and Rituximab were used. One child did not receive any treatment; a follow-up was established, adopting a "wait and see" policy. In all patients, symptoms and hemorrhage signs at diagnosis or during follow-up were mild to moderate, and were mostly characterized by petechiae and mild mucosal bleeding.
Spontaneous remission was obtained in 6 of 14 (42.8%) patients (4 of 6 males, 2 of 6 females) over a period of time from 9 to 90 months (mean 45 months; median 35.5 months) after the presentation of ITP.
At the time of remission of their chronic course, 6 children were aged between 8 and 16 years (mean age, 7 years 6 months; median age 7 years). In patients with spontaneous remission, treatment consisting of steroids was administered in 4 of 6 children, Ig i.v. in 2 of 6 children (one child was treated with combined steroids and Ig); one did not receive any treatment.
The probability of remission calculated by KaplanMeier analysis for all children included in the study was 24% at 4 years (95% CI) and 50% at 8 years (95% CI), respectively.
Further, Kaplan-Meier analysis was used to check whether the probability of remission was significantly related to gender, age (younger than 10 vs older than 10 years), PLT count at diagnosis and after 6 months (<20,000/μl vs ≥20,000/μl). The statistical significance was calculated using the Log Rank test and the Breslow test, showing a significant difference for PLT count at diagnosis. A higher remission rate was found in patients with a PLT count lower than 20,000/μl at diagnosis (Figure 1) .
Using the same analysis, the potential influence of age at diagnosis, gender, and PLT count after 6 months from diagnosis was evaluated, but no statistical significance was registered for these variables and the probability of spontaneous remission.
Discussion
About 10%-20% of children affected by ITP followed a chronic course [6, 12] . Previous studies attempted to identify the potential risk factor related to chronic outcome of the ITP. Among the factors promoting a chronic outcome of the disease, female sex, a platelet count higher than 20,000/μl and age at diagnosis above 10 years old were probably implicated [1, 13] . In any case, no criteria with a possible prognostic relevance concerning the outcome of chronic ITP have been identified to date.
The main aim of therapy is to reduce the risk of severe hemorrhage, considering that there is no direct connection with PLT count and that the chronic course of the disease is not influenced by administered treatment. However, it is necessary to emphasize that many of these patients affected by chronic ITP do not need long-term treatment. Moreover, the possibility of spontaneous remission must be considered, even if it can occur several years after the clinical presentation of the disease (in some cases it was observed after 15 years) [8] . This consideration is important to ensure proper management of these patients, because it provides the opportunity to postpone or even avoid surgical treatment, such as splenectomy, which increases septic risk by capsulated pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis). That risk, although it is more serious during the first few years of life, remains serious over an entire lifetime. In our present study, more than 40% of patients who became chronic had a remission, and none of them received a splenectomy.
The statistical analysis (Kaplan-Meier) of our group showed a probability of remission of 24% at 4 years and 50% at 8 years (CI 95%). Moreover, we evaluated the prognostic impact on spontaneous remission of some variable. The analysis shows a higher probability of complete remission for patients with a platelet count at diagnosis lower than 20,000/μl (p < 0.02).
factors such as age at diagnosis (younger vs older than 10 years old), gender, PLT count at diagnosis and after 6 months from diagnosis (<20,000/μl vs ≥ 0,000/μl). Among the features evaluated, PLT count at diagnosis was significantly associated with remission (p<0.022). In particular, patients who showed a PLT count lower than 20,000/μl were more likely to have a spontaneous remission. On the contrary, the other three factors did not show any significant correlation with remission.
The finding of spontaneous remission even few years after the diagnosis is certainly relevant. In our subset of patients, spontaneous remission has been registered up to 90 months from the diagnosis. This observation is relevant in view of the clinical history of these patients, as none of them showed any severe complication. It provides the opportunity to adopt a "wait and see" policy, indicating the use of symptomatic treatments instead of splenectomy as first line treatment; splenectomy should be reserved for selected cases who do not respond to medical treatment and have severe hemorrhagic manifestations [14] [15] [16] .
In conclusion, our analysis shows that gender, PLT count after 6 months from diagnosis, and age at diagnosis are not relevant predictive factors of a chronic course of the disease, whereas statistical significance is found for PLT count at diagnosis. In particular, a PLT count less than 20,000/μl is correlated with a higher probability of spontaneous remission even after several years from diagnosis. Furthermore, the clinical course of the disease was paucisymptomatic, and almost all patients showed no need for treatment. Therefore, our present results indicate that this subgroup of patients displays a less aggressive phenotype of the disease with a significant probability of spontaneous remission, and do not need any aggressive medical or surgical treatment.
